arrow
T

Timothy Kleinig

Royal Adelaide Hospital
H指数:57
被引数:2.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

“Everyone's Responsibility and No-One's Responsibility”: A Thematic Analysis of a Roundtable on the Complex Problem of Secondary Stroke Prevention in Australia

“人人有责,人人无责”:澳大利亚关于二级卒中预防复杂问题的圆桌会议主题分析

2026-07-060
OAAI
Anticoagulation associated intracerebral haemorrhage trends, treatment and outcomes in a metropolitan cohort: analysed by availability of specific versus non-specific reversal agents

抗凝相关颅内出血趋势、治疗及结局:基于特异性与非特异性逆转剂可用性的大都市队列分析

2026-05-010
OA
Safety and tolerability of Rinvecalinase Alfa (DM199) for acute ischemic stroke (ReMEDy1)

Rinvecalinase Alfa(DM199)治疗急性缺血性卒中的安全性与耐受性(ReMEDy1)

2025-11-060
OA
Endovascular treatment vs. best medical management for late window ischemic stroke patients with large vessel occlusion

血管内治疗与最佳药物治疗比较,用于晚期时间窗内的大血管闭塞缺血性卒中患者

2025-11-010
PRE
Co-Design of a Registry-Based Tailored Follow-up Service Intervention for People Living With Stroke: A Multiple Method Consensus Approach

基于注册表的个性化随访服务干预措施的设计:一种多方法共识方法

2025-10-290
OAAI
Development of a Health Text Message System to Support Stroke Prevention: A Component of the Love Your Brain Digital Platform

开发支持卒中预防的健康短信系统:这是“爱护大脑”数字平台的一个组成部分

2025-10-210
OAAI
Integrated UPper limb and Language Impairment and Functional Training (UPLIFT) after stroke: study protocol for an umbrella Bayesian Optimal Phase IIa clinical trial

卒中后综合上肢与语言障碍及功能训练(UPLIFT):一项伞式贝叶斯最优IIa期临床试验的研究方案

2025-09-250
PRE
Co-Designing a Digital Stroke Prevention Platform: Leveraging Lived Experience and Expert Advice

共同设计数字卒中预防平台:利用生活经验和专家建议

2025-05-220
OA
Processes Underpinning Successful Co-Design: Lessons From a Digital Health Project

成功协同设计的基础流程:来自一个数字健康项目的经验教训

2025-05-220
OA
Do Physicians Intuitively Select Slow Progressors for Thrombectomy in the Extended Time Window?

医生在扩展时间窗内直觉选择慢进展型患者进行血栓切除术吗?

2025-03-120
PRE
Extending the time window for tenecteplase by effective reperfusion of penumbral tissue in patients with large vessel occlusion: Rationale and design of a multicenter, prospective, randomized, open-label, blinded-endpoint, controlled phase 3 trial

通过对大血管闭塞患者的半影组织进行有效再灌注来延长tenecapase的时间窗: 多中心,前瞻性,随机,开放标签,盲法,对照3期试验的原理和设计

2024-12-310
PRE
Critical Care Decisions After Large Core Cerebral Infarctions: A Secondary Analysis From the SELECT2 Trial

大型核心脑梗死后的重症监护决策: SELECT2试验的二次分析

2024-12-090
OA
Association of Reperfusion and Procedural Characteristics with Endovascular Thrombectomy Outcomes in Large Core Stroke: Sub-Analysis from the SELECT2 Trial

再灌注和手术特点与大面积核心卒中患者血管内血栓切除术结局的关系: 来自SELECT2试验的亚分析

2024-11-071
PRE